DUBLIN--(BUSINESS WIRE)--Jul 5, 2018--The "Europe Breast Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

This research provides insights into Breast Cancer epidemiology, Breast Cancer diagnosed patients, and Breast Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Breast Cancer derived from epidemiological analysis, patients diagnosed with Breast Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Breast Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Breast Cancer prevalence, Breast Cancer diagnosis rate, and Breast Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered

1. Breast Cancer Disease Definition

2. Breast Cancer Patient Flow in Europe

3. Breast Cancer Patient Flow in Germany

4. Breast Cancer Patient Flow in France

5. Breast Cancer Patient Flow in Spain

6. Breast Cancer Patient Flow in Italy

7. Breast Cancer Patient Flow in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/35b3qt/breast_cancer_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180705005512/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Breast Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/05/2018 02:13 PM/DISC: 07/05/2018 02:13 PM

http://www.businesswire.com/news/home/20180705005512/en